My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Retirement
Markets
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Retirement
Markets
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
matthijs smith
Latest news and analysis on matthijs smith
August 18, 2015 10:46
Momentum building for Medtech microcap Dorsavi
Canaccord Genuity
Stockbroker
August 18, 2015 10:46
August 13, 2015 17:03
Getting pumped about AirXpanders
Canaccord Genuity
Stockbroker
August 13, 2015 17:03
June 02, 2015 17:15
Impedimed: Getting Significant Recognition In The Medical Community
Canaccord Genuity
Stockbroker
June 02, 2015 17:15
Advertisement
May 19, 2015 10:46
Ground-breaking study may lead to accelerated sales pipeline for Nanosonics
Canaccord Genuity
Stockbroker
May 19, 2015 10:46
April 23, 2014 12:11
QRXPharma just saw its market cap shrink 75% from $120mil to $30mil on the FDA saying 'no', as Matthijs smith warned Livewire yesterday: There is unlikely to...
Livewire Equities
Livewire
April 23, 2014 12:11
5
most
popular
Buy Hold Sell
Buy Hold Sell: 6 ASX stocks built to handle tough
conditions
Patrick Poke,
Livewire Markets
Equities
Question everything
Martin Conlon,
Schroders
Buy Hold Sell
Buy Hold Sell: 5 ASX ‘stayers’ to go the
distance
Patrick Poke,
Livewire Markets
Income
10 best ASX dividend stocks and income ETFs for 2027
Vishal Teckchandani,
Livewire Markets
view all
Advertisement
